Identification of palmitoyl protein thioesterase 1 in human THP-1 monocytes/macrophages and characterization of unique biochemical activities for this enzyme

The profiles of serine hydrolases in human and mouse macrophages are similar yet different. For instance, human macrophages express high levels of carboxylesterase 1 (CES1), whereas mouse macrophages have minimal amounts of the orthologous murine CES1. On the other hand, both species' macrophages exhibit limited expression of the canonical 2-arachidonoylglycerol (2-AG) hydrolytic enzyme, MAGL. Our previous study showed carboxylesterase 1 (CES1) was partly responsible for the hydrolysis of 2-AG (50%) and prostaglandin glyceryl esters (PG-Gs) (80-95%) in human THP1 monocytes/macrophages. However, MAGL and other endocannabinoid hydrolases, FAAH, ABHD6 and ABHD12, did not have a role because of either limited or no expression. Thus, another enzyme was hypothesized to be responsible for the remaining 2-AG hydrolysis activity following chemical inhibition and immunodepletion of CES1 (previous study) or CES1 gene knockdown (this study). Here we identified two candidate serine hydrolases in THP1 cell lysates by activity-based protein profiling (ABPP)–MudPIT and western blotting: cathepsin G and palmitoyl protein thioesterase 1 (PPT1). Both proteins exhibited similar electrophoretic properties to a serine hydrolase in THP1 cells detected by estimated that PPT1 contributed 32-40% of 2-AG hydrolysis activity in the THP1 cell line. In addition, pure recombinant PPT1 catalyzed the hydrolysis of 2-AG, PGE 2 -G and PGF 2 α -G, although the catalytic efficiency of 2-AG hydrolysis by PPT1 was ∼ 10-fold lower than CES1's. PPT1 was also insensitive to several chemical inhibitors that potently inhibit CES1, such as organophosphate poisons and JZL184. This is the first report to document the expression of PPT1 in a human monocyte/macrophage cell line and to show PPT1 can hydrolyze the natural substrates 2-AG and PG-Gs. These findings suggest that PPT1 may participate in endocannabinoid metabolism within specific cellular contexts, and highlights the functional redundancy often exhibited by enzymes involved in lipid metabolism. 5 distilled times. After the a microfuge the supernatant, the captured proteins were on-bead digested trypsin according to standard protocols 23 and the tryptic peptides were desalted and analyzed by LTQ LC-MS/MS. Peptides were separated on a 75-μm i.d. × 15 cm reverse phase C18 column (Thermo) controlled by an Ultimate 3000 nanoflow HPLC (Dionex) and eluted using a 55-min gradient from 2%-55% solvent B (99.9% acetonitrile, 0.1% formic acid) at a flow rate of 0.3 μl/min, and further introduced into an LTQ-OrbiTrap Velos mass spectrometer (Thermo Fisher). The mass spectrometer was operated in LTQ data-dependent mode, automatically switching between MS and MS/MS. Full scan MS spectra (300-2,000 amu) were analyzed in a profile mode by the LTQ analyzer. The seven most intense ions in a scan were selected for collision-induced fragmentation (CID) in the LTQ at normalized collision energy of 35% and activation time of 40 ms. The acquired data were analyzed by Proteome Discoverer 1.4 (Thermo Fisher) using SEQUEST algorithm and a human Uniprot database along with the reversed decoy database. Searches were done using a precursor mass tolerance of 1.8 Da and fragment tolerance of 0.5 Da and the following dynamic modifications were included: oxidation on methionine, N-terminal acetylation, and carbamidomethylation on cysteine. The results were filtered using normalized XCorr values for different charge states 24 and were accepted as valid identifications only if the XCorr values were >1.5, >2.5, >3.75 and >4 for singly, doubly, triply and quadruply charged peptides, respectively. Moreover, the maximum delta Cn was 0.15 for peptides. Proteins hydrolyze the endogenous cannabinoid 2-arachidonoylglycerol (2-AG) and two prostaglandin glyceryl esters, PGE 2 -G and PGF 2 α -G, in vitro . These findings suggest that PPT1 may also have a role in degrading endocannabinoids in certain cellular niches, especially in cell types lacking or having limited expression of MAGL, FAAH, ABHD6, ABHD12 and CES1. Furthermore, we characterized the hydrolytic efficiency of PPT1 using both 2-AG and PG-G substrates and compared the kinetic parameters to CES1, MAGL and FAAH. We also investigated the relative contributions of PPT1 and CES1 to the hydrolysis of 2-AG in human THP1 cells using chemical inhibitors, immunoprecipitation of PPT1, and knockdown of CES1 expression using a lentiviral shRNA system. Collectively, the results suggest that PPT1 has the ability to recognize and hydrolyze lipid glyceryl esters in human THP1 cells, and that PPT1 accounts for ∼ 32% of the 2-AG hydrolytic activity while CES1 contributes ∼ 51%.

[1]  G. Muccioli,et al.  Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy. , 2014, Drug discovery today.

[2]  P. Potter,et al.  Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597. , 2012, Biochemical pharmacology.

[3]  B. Cravatt,et al.  DAGLβ Inhibition Perturbs a Lipid Network Involved in Macrophage Inflammatory Responses , 2012, Nature chemical biology.

[4]  M. Ross,et al.  Examination of the carboxylesterase phenotype in human liver. , 2012, Archives of biochemistry and biophysics.

[5]  Raymond E Moellering,et al.  How chemoproteomics can enable drug discovery and development. , 2012, Chemistry & biology.

[6]  D. Nomura,et al.  Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation , 2011, Science.

[7]  M. Ross,et al.  Catabolism of 4-hydroxy-2-trans-nonenal by THP1 monocytes/macrophages and inactivation of carboxylesterases by this lipid electrophile. , 2011, Chemico-biological interactions.

[8]  Lawrence J. Marnett,et al.  Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways , 2011, Chemical reviews.

[9]  Ariel D. Quiroga,et al.  Role of endoplasmic reticulum neutral lipid hydrolases , 2011, Trends in Endocrinology & Metabolism.

[10]  Dan S. Tawfik,et al.  The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. , 2011, Biochemistry.

[11]  P. Potter,et al.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2. , 2010, Chemical research in toxicology.

[12]  Sherry L. Niessen,et al.  Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening , 2010, Proceedings of the National Academy of Sciences.

[13]  Agnes L. Bodor,et al.  The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors , 2010, Nature Neuroscience.

[14]  S. Hofmann,et al.  Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis. , 2010, Molecular genetics and metabolism.

[15]  Anna E Speers,et al.  Activity‐Based Protein Profiling (ABPP) and Click Chemistry (CC)–ABPP by MudPIT Mass Spectrometry , 2009, Current protocols in chemical biology.

[16]  V. Marzo,et al.  The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. , 2009, Pharmacological research.

[17]  P. Potter,et al.  Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. , 2008, Biochimica et biophysica acta.

[18]  F. Mach,et al.  The Role of the Endocannabinoid System in Atherosclerosis , 2008, Journal of neuroendocrinology.

[19]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[20]  L. Marnett,et al.  Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase. , 2007, Biochemistry.

[21]  B. Cravatt,et al.  A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. , 2007, Journal of the American Chemical Society.

[22]  M. Jauhiainen,et al.  Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1) – distinct characteristics in neurons , 2007, BMC Cell Biology.

[23]  E. Cudaback,et al.  Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells , 2007, The Journal of Neuroscience.

[24]  S. Hofmann,et al.  Thematic review series: Lipid Posttranslational Modifications. Lysosomal metabolism of lipid-modified proteins Published, JLR Papers in Press, April 20, 2006. , 2006, Journal of Lipid Research.

[25]  S. Hofmann,et al.  Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: Implications for treatment of infantile neuronal ceroid lipofuscinosis , 2006, Journal of Inherited Metabolic Disease.

[26]  Lawrence J Marnett,et al.  Glycerylprostaglandin Synthesis by Resident Peritoneal Macrophages in Response to a Zymosan Stimulus* , 2005, Journal of Biological Chemistry.

[27]  P. Beroza,et al.  Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. , 2005, Journal of medicinal chemistry.

[28]  L. Petrocellis,et al.  The endocannabinoid system: a general view and latest additions , 2004, British journal of pharmacology.

[29]  H. Goebel,et al.  Current State of Clinical and Morphological Features in Human NCL , 2004, Brain pathology.

[30]  C. Newton,et al.  The cannabinoid system and immune modulation , 2003, Journal of leukocyte biology.

[31]  L. Ahtiainen,et al.  Palmitoyl protein thioesterase 1 is targeted to the axons in neurons , 2003, The Journal of comparative neurology.

[32]  L. Hedstrom Serine protease mechanism and specificity. , 2002, Chemical reviews.

[33]  J. Yates,et al.  Probability-based validation of protein identifications using a modified SEQUEST algorithm. , 2002, Analytical chemistry.

[34]  R. Hammer,et al.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Hofmann,et al.  Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. , 2001, Human molecular genetics.

[36]  C. Morton,et al.  Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression , 2000, Molecular biotechnology.

[37]  J. Clardy,et al.  Structural Basis for the Insensitivity of a Serine Enzyme (Palmitoyl-Protein Thioesterase) to Phenylmethylsulfonyl Fluoride* , 2000, The Journal of Biological Chemistry.

[38]  J. Widom,et al.  The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Paunio,et al.  Expression of palmitoyl protein thioesterase in neurons. , 2000, Molecular genetics and metabolism.

[40]  S. Ghosh,et al.  Cholesteryl ester hydrolase in human monocyte/macrophage: cloning, sequencing, and expression of full-length cDNA. , 2000, Physiological genomics.

[41]  B. Cravatt,et al.  Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Peltonen,et al.  Developmental expression of palmitoyl protein thioesterase in normal mice. , 1999, Brain research. Developmental brain research.

[43]  J. Suopanki,et al.  The expression of palmitoyl-protein thioesterase is developmentally regulated in neural tissues but not in nonneural tissues. , 1999, Molecular genetics and metabolism.

[44]  C. Bennett,et al.  Tissue expression and subcellular localization of CLN3, the Batten disease protein. , 1999, Molecular genetics and metabolism.

[45]  S. Hofmann,et al.  Lysosomal Targeting of Palmitoyl-protein Thioesterase* , 1996, The Journal of Biological Chemistry.

[46]  S. Hofmann,et al.  cDNA and genomic cloning of human palmitoyl-protein thioesterase (PPT), the enzyme defective in infantile neuronal ceroid lipofuscinosis. , 1996, Genomics.

[47]  L. Peltonen,et al.  Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis , 1995, Nature.

[48]  S. Hofmann,et al.  Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. , 1993, The Journal of biological chemistry.

[49]  A. Borazjani,et al.  Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon. , 2012, Toxicology and applied pharmacology.

[50]  M. Lehtovirta,et al.  Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). , 2001, Human molecular genetics.

[51]  Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .